Global Neurological Disorder Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 85 pages | ID: G4D90799C99EN
LP Information

Abstracts

According to this study, the global Neurological Disorder Diagnostics market size will reach US$ 14650 million by 2031.

Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Neurological Disorder Diagnostics Industry Forecast” looks at past sales and reviews total world Neurological Disorder Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurological Disorder Diagnostics sales for 2025 through 2031. With Neurological Disorder Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disorder Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Neurological Disorder Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurological Disorder Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disorder Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disorder Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disorder Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disorder Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Imaging Techniques
• In Vitro Diagnostics Techniques

Segmentation by Application:

• Hospitals and Clinics
• Diagnostic Centers
• Ambulatory Care Centers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Siemens
• Philips
• GE
• Esaote
• Masimo
• Croton Healthcare
• Neusoft

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neurological Disorder Diagnostics Market Size (2020-2031)
  2.1.2 Neurological Disorder Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Neurological Disorder Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Neurological Disorder Diagnostics Segment by Type
  2.2.1 Imaging Techniques
  2.2.2 In Vitro Diagnostics Techniques
2.3 Neurological Disorder Diagnostics Market Size by Type
  2.3.1 Neurological Disorder Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Neurological Disorder Diagnostics Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Diagnostic Centers
  2.4.3 Ambulatory Care Centers
2.5 Neurological Disorder Diagnostics Market Size by Application
  2.5.1 Neurological Disorder Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)

3 NEUROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Neurological Disorder Diagnostics Market Size Market Share by Player
  3.1.1 Global Neurological Disorder Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Neurological Disorder Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Neurological Disorder Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEUROLOGICAL DISORDER DIAGNOSTICS BY REGION

4.1 Neurological Disorder Diagnostics Market Size by Region (2020-2025)
4.2 Global Neurological Disorder Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurological Disorder Diagnostics Market Size Growth (2020-2025)
4.4 APAC Neurological Disorder Diagnostics Market Size Growth (2020-2025)
4.5 Europe Neurological Disorder Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Neurological Disorder Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Neurological Disorder Diagnostics Market Size by Country (2020-2025)
5.2 Americas Neurological Disorder Diagnostics Market Size by Type (2020-2025)
5.3 Americas Neurological Disorder Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neurological Disorder Diagnostics Market Size by Region (2020-2025)
6.2 APAC Neurological Disorder Diagnostics Market Size by Type (2020-2025)
6.3 APAC Neurological Disorder Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Neurological Disorder Diagnostics Market Size by Country (2020-2025)
7.2 Europe Neurological Disorder Diagnostics Market Size by Type (2020-2025)
7.3 Europe Neurological Disorder Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neurological Disorder Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET FORECAST

10.1 Global Neurological Disorder Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Neurological Disorder Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Neurological Disorder Diagnostics Forecast
  10.1.3 APAC Neurological Disorder Diagnostics Forecast
  10.1.4 Europe Neurological Disorder Diagnostics Forecast
  10.1.5 Middle East & Africa Neurological Disorder Diagnostics Forecast
10.2 Americas Neurological Disorder Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Neurological Disorder Diagnostics Forecast
  10.2.2 Canada Market Neurological Disorder Diagnostics Forecast
  10.2.3 Mexico Market Neurological Disorder Diagnostics Forecast
  10.2.4 Brazil Market Neurological Disorder Diagnostics Forecast
10.3 APAC Neurological Disorder Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Neurological Disorder Diagnostics Market Forecast
  10.3.2 Japan Market Neurological Disorder Diagnostics Forecast
  10.3.3 Korea Market Neurological Disorder Diagnostics Forecast
  10.3.4 Southeast Asia Market Neurological Disorder Diagnostics Forecast
  10.3.5 India Market Neurological Disorder Diagnostics Forecast
  10.3.6 Australia Market Neurological Disorder Diagnostics Forecast
10.4 Europe Neurological Disorder Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Neurological Disorder Diagnostics Forecast
  10.4.2 France Market Neurological Disorder Diagnostics Forecast
  10.4.3 UK Market Neurological Disorder Diagnostics Forecast
  10.4.4 Italy Market Neurological Disorder Diagnostics Forecast
  10.4.5 Russia Market Neurological Disorder Diagnostics Forecast
10.5 Middle East & Africa Neurological Disorder Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Neurological Disorder Diagnostics Forecast
  10.5.2 South Africa Market Neurological Disorder Diagnostics Forecast
  10.5.3 Israel Market Neurological Disorder Diagnostics Forecast
  10.5.4 Turkey Market Neurological Disorder Diagnostics Forecast
10.6 Global Neurological Disorder Diagnostics Forecast by Type (2026-2031)
10.7 Global Neurological Disorder Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Neurological Disorder Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Siemens
  11.1.1 Siemens Company Information
  11.1.2 Siemens Neurological Disorder Diagnostics Product Offered
  11.1.3 Siemens Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Siemens Main Business Overview
  11.1.5 Siemens Latest Developments
11.2 Philips
  11.2.1 Philips Company Information
  11.2.2 Philips Neurological Disorder Diagnostics Product Offered
  11.2.3 Philips Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Philips Main Business Overview
  11.2.5 Philips Latest Developments
11.3 GE
  11.3.1 GE Company Information
  11.3.2 GE Neurological Disorder Diagnostics Product Offered
  11.3.3 GE Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GE Main Business Overview
  11.3.5 GE Latest Developments
11.4 Esaote
  11.4.1 Esaote Company Information
  11.4.2 Esaote Neurological Disorder Diagnostics Product Offered
  11.4.3 Esaote Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Esaote Main Business Overview
  11.4.5 Esaote Latest Developments
11.5 Masimo
  11.5.1 Masimo Company Information
  11.5.2 Masimo Neurological Disorder Diagnostics Product Offered
  11.5.3 Masimo Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Masimo Main Business Overview
  11.5.5 Masimo Latest Developments
11.6 Croton Healthcare
  11.6.1 Croton Healthcare Company Information
  11.6.2 Croton Healthcare Neurological Disorder Diagnostics Product Offered
  11.6.3 Croton Healthcare Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Croton Healthcare Main Business Overview
  11.6.5 Croton Healthcare Latest Developments
11.7 Neusoft
  11.7.1 Neusoft Company Information
  11.7.2 Neusoft Neurological Disorder Diagnostics Product Offered
  11.7.3 Neusoft Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Neusoft Main Business Overview
  11.7.5 Neusoft Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neurological Disorder Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Neurological Disorder Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Imaging Techniques
Table 4. Major Players of In Vitro Diagnostics Techniques
Table 5. Neurological Disorder Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Neurological Disorder Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Neurological Disorder Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Neurological Disorder Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Neurological Disorder Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Neurological Disorder Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Neurological Disorder Diagnostics Key Players Head office and Products Offered
Table 14. Neurological Disorder Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neurological Disorder Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Neurological Disorder Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Neurological Disorder Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Neurological Disorder Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Neurological Disorder Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Neurological Disorder Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Neurological Disorder Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Neurological Disorder Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Neurological Disorder Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Neurological Disorder Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Neurological Disorder Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Neurological Disorder Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Neurological Disorder Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Neurological Disorder Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Neurological Disorder Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Neurological Disorder Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Neurological Disorder Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Neurological Disorder Diagnostics
Table 39. Key Market Challenges & Risks of Neurological Disorder Diagnostics
Table 40. Key Industry Trends of Neurological Disorder Diagnostics
Table 41. Global Neurological Disorder Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Neurological Disorder Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Neurological Disorder Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Neurological Disorder Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Siemens Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 46. Siemens Neurological Disorder Diagnostics Product Offered
Table 47. Siemens Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Siemens Main Business
Table 49. Siemens Latest Developments
Table 50. Philips Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 51. Philips Neurological Disorder Diagnostics Product Offered
Table 52. Philips Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Philips Main Business
Table 54. Philips Latest Developments
Table 55. GE Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 56. GE Neurological Disorder Diagnostics Product Offered
Table 57. GE Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. GE Main Business
Table 59. GE Latest Developments
Table 60. Esaote Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 61. Esaote Neurological Disorder Diagnostics Product Offered
Table 62. Esaote Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Esaote Main Business
Table 64. Esaote Latest Developments
Table 65. Masimo Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 66. Masimo Neurological Disorder Diagnostics Product Offered
Table 67. Masimo Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Masimo Main Business
Table 69. Masimo Latest Developments
Table 70. Croton Healthcare Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 71. Croton Healthcare Neurological Disorder Diagnostics Product Offered
Table 72. Croton Healthcare Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Croton Healthcare Main Business
Table 74. Croton Healthcare Latest Developments
Table 75. Neusoft Details, Company Type, Neurological Disorder Diagnostics Area Served and Its Competitors
Table 76. Neusoft Neurological Disorder Diagnostics Product Offered
Table 77. Neusoft Neurological Disorder Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Neusoft Main Business
Table 79. Neusoft Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neurological Disorder Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurological Disorder Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Neurological Disorder Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Neurological Disorder Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Neurological Disorder Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Neurological Disorder Diagnostics Market Size Market Share by Type in 2024
Figure 10. Neurological Disorder Diagnostics in Hospitals and Clinics
Figure 11. Global Neurological Disorder Diagnostics Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Neurological Disorder Diagnostics in Diagnostic Centers
Figure 13. Global Neurological Disorder Diagnostics Market: Diagnostic Centers (2020-2025) & ($ millions)
Figure 14. Neurological Disorder Diagnostics in Ambulatory Care Centers
Figure 15. Global Neurological Disorder Diagnostics Market: Ambulatory Care Centers (2020-2025) & ($ millions)
Figure 16. Global Neurological Disorder Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Neurological Disorder Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Neurological Disorder Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Neurological Disorder Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Neurological Disorder Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Neurological Disorder Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Neurological Disorder Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Neurological Disorder Diagnostics Value Market Share by Country in 2024
Figure 24. United States Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Neurological Disorder Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Neurological Disorder Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Neurological Disorder Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Neurological Disorder Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Neurological Disorder Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Neurological Disorder Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Neurological Disorder Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Neurological Disorder Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Neurological Disorder Diagnostics Market Size 2026-2031 ($ millions)